Blood eosinophil counts, withdrawal of inhaled corticosteroids and risk of COPD exacerbations and mortality in the Clinical Practice Research Datalink (CPRD)

O. Oshagbemi (Maastricht, Netherlands), F. Franssen (Maastricht, Netherlands), E. Wouters (Maastricht, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), J. Driessen (Maastricht, Netherlands), A. De Boer (Maastricht, Netherlands), F. Devries (Maastricht, Netherlands), D. Braeken (Maastricht, Netherlands)

Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Session: COPD clinical studies: bronchodilators, corticosteroids and more
Session type: Poster Discussion
Number: 3373

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Oshagbemi (Maastricht, Netherlands), F. Franssen (Maastricht, Netherlands), E. Wouters (Maastricht, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), J. Driessen (Maastricht, Netherlands), A. De Boer (Maastricht, Netherlands), F. Devries (Maastricht, Netherlands), D. Braeken (Maastricht, Netherlands). Blood eosinophil counts, withdrawal of inhaled corticosteroids and risk of COPD exacerbations and mortality in the Clinical Practice Research Datalink (CPRD). 3373

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: